The results of this study, as well as those of previously published studies, suggest that class I mutations that affect myeloblast proliferation, such as FLT3, RAS and KIT, are infrequent in AML associated with erythroid predominance [5], [7], [10], [17]. This evidence concerns the gene KIT and acute myeloid leukemia.